HUTCHMED (China) Ltd Files 6-K Report
Ticker: HMDCF · Form: 6-K · Filed: Dec 31, 2024 · CIK: 1648257
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer
TL;DR
HUTCHMED (China) Ltd filed a 6-K on 12/31/24, confirming 20-F annual reports.
AI Summary
HUTCHMED (China) Limited, formerly Hutchison China MediTech Ltd, filed a Form 6-K on December 31, 2024. This report is for the month of December 2024 and indicates the company files annual reports under Form 20-F. The company is based in Hong Kong and operates in the Pharmaceutical Preparations industry.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding HUTCHMED's reporting status and corporate information.
Risk Assessment
Risk Level: low — This is a routine filing that does not contain new financial or operational information that would typically impact risk.
Key Players & Entities
- HUTCHMED (China) Limited (company) — Registrant
- Hutchison China MediTech Ltd (company) — Former Company Name
- 20241231 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the company makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.
What is HUTCHMED's primary industry?
HUTCHMED (China) Limited is in the Pharmaceutical Preparations industry, with SIC code 2834.
What is the principal executive office address for HUTCHMED?
The principal executive offices are located at 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong.
Does HUTCHMED file annual reports under Form 20-F or 40-F?
HUTCHMED indicates that it files annual reports under cover of Form 20-F.
When was HUTCHMED's name changed from Hutchison China MediTech Ltd?
The date of the name change from Hutchison China MediTech Ltd to HUTCHMED (CHINA) LIMITED was July 16, 2015.
Filing Stats: 164 words · 1 min read · ~1 pages · Grade level 13.4 · Accepted 2024-12-31 07:50:30
Filing Documents
- hcm-20241231x6k.htm (6-K) — 20KB
- hcm-20241231xex99d1.htm (EX-99.1) — 9KB
- hcm-20241231xex99d1001.gif (GRAPHIC) — 4KB
- 0001648257-24-000101.txt ( ) — 36KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of December 2024 Commission File Number: 001-37710 HUTCHMED (CHINA) LIMITED (Translation of registrant's name into English) 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F HUTCHMED (CHINA) LIMITED Form 6-K EXHIBIT INDEX Exhibit No. Description Exhibit 99.1 Announcement relating to appointment of Cavendish as joint corporate broker in London 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. HUTCHMED (CHINA) LIMITED By: /s/ Johnny Cheng Name: Johnny Cheng Title: Chief Financial Officer Date: December 31, 2024 3